Smoking Cessation Flashcards

1
Q

• Cigarette smoking remains the greatest

single cause of

A

preventable illness and

premature death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In the United States, smoking kills more

A

n 443,000 adults each year; this is

about 1 of every 5 deaths

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

“5 A’s” Model for Treating

Tobacco Use and Dependence

A

• Ask (screen all patients for tobacco use)
• Advise tobacco users to quit
• Assess willingness to make a quit attempt
• Assist with quitting (offer medication and
provide or refer to counseling)
• Arrange follow-up contacts, beginning
within the first week after the quit date

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Initial Therapy Selection - First line

A

nicotine replacement therapy,

varenicline, and bupropion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Initial Therapy Selection - AIM

A

reduce symptoms of nicotine

withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Initial Therapy Selection

- choices based on

A

patient preference with

some contraindications to certain drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Initial Therapy Selection - Most recommended

A

varenicline or a

combination of 2 NRT products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

gum doubles

A

the cessation success rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

gum ADR

A

Mouth and throat
soreness, jaw muscle ache, eructation
(belching), and hiccups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

gum use

A

Chew the gum slowly and intermittently for

about 30 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

gum education - avoid

A

Avoid eating or drinking while chewing and

for 15 minutes before chewing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nicotine Lozenges ADR

A

Adverse effects: Mouth irritation,

dyspepsia, nausea, and hiccups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Nicotine Lozenges use

A

Allow lozenge to dissolve in mouth over 20

to 30 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nicotine Lozenges no eating or drinking for

A

• No eating or drinking for 15 minutes before
dosing and while the lozenge is in the
mouth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nicotine Lozenges do not

A

chew or swallow the lozenge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NicoDerm CQ and Nicotrol ADR

A

Adverse effects: Short-lived erythema,

itching, and burning occur under the patch

17
Q

NicoDerm CQ and Nicotrol applied

A

Applied once a day to clean, dry, nonhairy

skin of the upper body or upper arm

18
Q

NicoDerm CQ and Nicotrol application site

A

Application site should be changed daily

and not reused for at least 1 week

19
Q

Nicotine Inhaler ADR

A

Adverse effects: Dyspepsia, coughing,

throat irritation, oral burning, and rhinitis

20
Q

Nicotine Inhaler frequent puffing over

A

20 min

21
Q

Nicotine Inhaler should not be used with

A

patients with

asthma

22
Q

Nicotine Nasal Spray ADR

A

• Adverse effects: Rhinitis, sneezing,
coughing, watering eyes, and nasal and
throat irritation

23
Q

Nicotine Nasal Spray levels

A

rise rapidly

24
Q

Nicotine Nasal Spray provides some of the

A

subjective

pleasure associated with cigarettes

25
Q

Bupropion SR [Zyban,

Buproban] class

A

atypical antidepressant

26
Q

Bupropion SR [Zyban,

Buproban] reduces

A

Reduces the urge to smoke and some
symptoms of nicotine withdrawal, such as
irritability and anxiety

27
Q

Bupropion SR [Zyban,

Buproban] adr

A

Dry mouth and insomnia

28
Q

Bupropion SR [Zyban,

Buproban] less effect than

A

combination NRT or

varenciline

29
Q

Varenicline [Chantix, Champix] is a

A

• Partial agonist at nicotinic receptors

30
Q

Varenicline [Chantix, Champix] most effective

A

Most effective aid for smoking cessation

31
Q

Varenicline [Chantix, Champix] class

A

Atypical antidepressant

32
Q

Varenicline [Chantix, Champix] ADR

A

Adverse effects: Nausea, sleep disturbances,

headaches, abnormal dreams, constipation, dry m

33
Q

Varenicline [Chantix, Champix] serious

A

• Serious neuropsychiatric effects

34
Q

Varenicline [Chantix, Champix] can have

A

Cardiovascular events

35
Q

Varenicline [Chantix, Champix] us athorits have banned

A

U.S. authorities have banned the use of varenicline by
truck drivers, bus drivers, airplane pilots, and air traffic
controllers

36
Q

Products Not Recommended

A
• Naltrexone
• Silver acetate
• Beta blockers
• Benzodiazepines
• Antidepressants other than bupropion SR
and nortriptyline
• Electronic cigarettes (e-cigarettes)
37
Q

Follow-up

A
• Follow-up in-person or by phone in 1 to 2
weeks after initiation of any therapy to
monitor for adverse effects, reinforce
adherence to medication, and provide
support